Well, we haven't even talked about everything we should talk about with this, but we're out of time
#Hepatology #MASLD #Tirzepatide #SGLT2i #RealWorldEvidence #ObesityMedicine #LiverDisease #CardiometabolicHealth To view or add a comment, sign in GLP1 RAs and Pancreatitis: Evidence from the 2025 Gastroenterology Metaanalysis As GLP1 receptor agonists continue to transform diabetes and obesity care, questions about pancreatitis risk remain common among clinicians and patients
J Biol Chem 270:14811484 Ursini F, Maiorino M, Brigelius-Flohe R, Aumann KD, Roveri A, Schomburg D, Flohe L (1995) Diversity of glutathione peroxidases
Hence, further exploration of the impact of the gut microbiota on ferroptosis will help us gain a deeper understanding of the mechanisms underlying disease occurrence and progression, as well as strategies to delay ferroptosis
Natural immunomodulators are becoming popular due to their broad application in disease prevention and treatment via changes in immune response or oxidant-antioxidant status (42)
Ozbey-Yucel U, Ucar A, Aydogan Z, Tokgoz-Yilmaz S, Beton S